Peter A. Hecker, Ph.D.

Peter A. Hecker, Ph.D.

Knobbe Martens

Contact
View Bio
RSS

Latest Posts › Clinical Trials

Share:

Right to Try Act Gives Terminal Patients Opportunity to Try Early Therapies

Often those with terminal illnesses wish to try new experimental therapies. Now they can if they are willing to accept the risks. On May 30, 2018, President Trump signed into law the Right to Try Act. The Act allows eligible...more

6/22/2018  /  Clinical Trials , Health Tourism , Manufacturer Liability , Non-Approved Drugs , Pharmaceutical Industry , Right to Try , Terminal Illness Treatments , Trump Administration
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide